Stockscreener 앱 받기
32.88
3.89%
1.28
전일 마감가:
$31.60
열려 있는:
$32
하루 거래량:
86,080
Relative Volume:
0.12
시가총액:
$2.06B
수익:
$681.88M
순이익/손실:
$122.63M
주가수익비율:
15.58
EPS:
2.11
순현금흐름:
$220.18M
1주 성능:
+2.40%
1개월 성능:
-4.84%
6개월 성능:
-4.59%
1년 성능:
+7.92%
1일 변동 폭
$31.87
$32.84
1주일 범위
$31.25
$32.84
52주 변동 폭
$26.47
$41.61
하모니 바이오 Stock (HRMY) Company Profile
명칭
Harmony Biosciences Holdings Inc
전화
(484) 539-9800
주소
630 W GERMANTOWN PIKE, PLYMOUTH MEETING
HRMY을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
HRMY
Harmony Biosciences Holdings Inc
|
32.83 | 2.06B | 681.88M | 122.63M | 220.18M | 2.11 |
|
VRTX
Vertex Pharmaceuticals Inc
|
446.81 | 115.95B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
524.91 | 56.52B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
323.00 | 39.44B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
561.76 | 35.14B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
240.30 | 28.51B | 3.81B | -644.79M | -669.77M | -6.24 |
하모니 바이오 Stock (HRMY) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-06-02 | 재개 | Oppenheimer | Outperform |
| 2025-02-11 | 개시 | Deutsche Bank | Buy |
| 2024-12-17 | 개시 | H.C. Wainwright | Buy |
| 2024-10-10 | 재개 | Raymond James | Outperform |
| 2024-09-10 | 개시 | UBS | Buy |
| 2024-06-21 | 개시 | Citigroup | Buy |
| 2024-01-02 | 다운그레이드 | BofA Securities | Neutral → Underperform |
| 2023-09-25 | 다운그레이드 | Goldman | Neutral → Sell |
| 2023-09-07 | 개시 | Berenberg | Buy |
| 2023-04-20 | 개시 | BofA Securities | Neutral |
| 2022-10-14 | 업그레이드 | Janney | Neutral → Buy |
| 2022-10-14 | 업그레이드 | Jefferies | Hold → Buy |
| 2022-08-03 | 다운그레이드 | Jefferies | Buy → Hold |
| 2022-07-13 | 다운그레이드 | Goldman | Buy → Neutral |
| 2022-07-07 | 개시 | Mizuho | Buy |
| 2022-04-14 | 개시 | Cantor Fitzgerald | Overweight |
| 2021-12-01 | 개시 | Oppenheimer | Outperform |
| 2021-11-04 | 개시 | Raymond James | Outperform |
| 2021-09-23 | 개시 | Needham | Buy |
| 2021-03-29 | 업그레이드 | Goldman | Neutral → Buy |
| 2020-09-14 | 개시 | Goldman | Neutral |
| 2020-09-14 | 개시 | Jefferies | Buy |
| 2020-09-14 | 개시 | Piper Sandler | Overweight |
모두보기
하모니 바이오 주식(HRMY)의 최신 뉴스
Lupin Concedes To Harmony On Generic Wakix With 2030 Launch Agreement - insights.citeline.com
Harmony Biosciences Presents Promising Preclinical Data for Novel Narcolepsy Treatment - MyChesCo
Rhumbline Advisers Increases Holdings in Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) - Defense World
(HRMY) Investment Analysis - news.stocktradersdaily.com
Equities Analysts Set Expectations for HRMY FY2026 Earnings - Defense World
Harmony Biosciences Presents Preclinical Data Demonstrating Sign - GuruFocus
Harmony Biosciences to begin human trials of narcolepsy drug in 2025 By Investing.com - Investing.com South Africa
Harmony Biosciences to begin human trials of narcolepsy drug in 2025 - Investing.com Canada
HRMY: Harmony Biosciences Shows Promising Preclinical Data for BP1.15205 | HRMY Stock News - GuruFocus
Harmony Biosciences (HRMY) Presents Preclinical Data Demonstrating Significant Wake-Promoting and Cataplexy-Suppressing Effects of BP1.15205 - StreetInsider
Harmony Biosciences Presents Preclinical Data Demonstrating Significant Wake-Promoting and Cataplexy-Suppressing Effects of BP1.15205 in Narcolepsy at SLEEP 2025 - Business Wire
Harmony Biosciences Holdings, Inc. (HRMY): A Bull Case Theory - MSN
Harmony Biosciences Reaches Settlement with Lupin Over WAKIX® Patent Litigation - MSN
Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) Shares Acquired by California State Teachers Retirement System - Defense World
Transcript : Harmony Biosciences Holdings, Inc. Presents at Goldman Sachs 46th Annual Global Healthcare Conference 2025, Jun-09-2025 03 - MarketScreener
Harmony Biosciences settles patent litigation with Lupin By Investing.com - Investing.com South Africa
Harmony Biosciences, Lupin reach agreement on Wakix generic launch - MSN
Harmony Biosciences: If It Ain't Broke (NASDAQ:HRMY) - Seeking Alpha
Harmony Biosciences Strengthens Patent Position With Favorable Settlement in ANDA Litigation - BioSpace
Harmony Biosciences (HRMY) Settles Patent Dispute with Lupin | HRMY Stock News - GuruFocus
Harmony Biosciences settles patent litigation with Lupin - Investing.com Australia
Harmony Biosciences Strengthens Patent Position With Favorable Settlement In ANDA Litigation - MarketScreener
Harmony Biosciences Strengthens Patent Position With Favorable S - GuruFocus
Harmony Biosciences Strengthens Patent Position With Favorable Settlement in ANDA Litigation | HRMY Stock News - GuruFocus
Harmony Biosciences to Participate in Goldman Sachs 46th Annual Global Healthcare Conference | HRMY Stock News - GuruFocus
Harmony Biosciences to Participate in Goldman Sachs 46th Annual Global Healthcare Conference - Yahoo Finance
Top 5 US Stocks To Buy In June 2025 - Investing.com
Harmony Biosciences (NASDAQ:HRMY) Now Covered by Analysts at Oppenheimer - Defense World
Where Harmony Biosciences Hldgs Stands With Analysts - Benzinga
Oppenheimer Sets $61 Price Target for Harmony Biosciences (HRMY) | HRMY Stock News - GuruFocus
(HRMY) On The My Stocks Page - news.stocktradersdaily.com
Oppenheimer assumes Outperform rating on Harmony Biosciences stock By Investing.com - Investing.com Nigeria
Oppenheimer assumes Outperform rating on Harmony Biosciences stock - Investing.com
Harmony Biosciences (HRMY) Receives Outperform Rating from Oppen - GuruFocus
Oppenheimer Assumes Harmony Biosciences Holdings Inc. (HRMY) at Outperform - StreetInsider
Oppenheimer Sets $61 Price Target for Harmony Biosciences (HRMY) - GuruFocus
Nuveen Asset Management LLC Buys 8,193 Shares of Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) - Defense World
MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. Grows Stock Holdings in Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) - Defense World
Bank of America Corp DE Decreases Stock Holdings in Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) - Defense World
Ameriprise Financial Inc. Purchases 18,730 Shares of Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) - Defense World
Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) Given Average Recommendation of “Buy” by Analysts - Defense World
When (HRMY) Moves Investors should Listen - news.stocktradersdaily.com
Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) Shares Bought by Deutsche Bank AG - Defense World
A Piece Of The Puzzle Missing From Harmony Biosciences Holdings, Inc.'s (NASDAQ:HRMY) 26% Share Price Climb - simplywall.st
BNP Paribas Financial Markets Invests $2.03 Million in Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) - Defense World
Harmony Biosciences (NASDAQ:HRMY) Price Target Raised to $48.00 - Defense World
The Manufacturers Life Insurance Company Acquires 2,144 Shares of Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) - Defense World
Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) Stock Position Increased by Northern Trust Corp - Defense World
Comerica Bank Acquires 2,919 Shares of Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) - Defense World
Harmony Biosciences (NASDAQ:HRMY) Upgraded at Cantor Fitzgerald - Defense World
Harmony Biosciences (HRMY): Mizuho Raises Price Target to $48 | - GuruFocus
하모니 바이오 (HRMY) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.27%
0.04%
자본화:
|
볼륨(24시간):